Catechins inhibit vascular endothelial growth factor production and cyclooxygenase-2 expression in human dental pulp cells

International Endodontic Journal

Volumn 48, Issue 3, 2015, Pages 277-282

  Nakanishi, T ^a   Mukai, K ^a   Hosokawa, Y ^a   Takegawa, D ^a   Matsuo, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Catechin; Cyclooxygenase 2; Dental pulp; Vascular endothelial growth factor

Indexed keywords

CATECHIN; CYCLOOXYGENASE 2 INHIBITOR; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR; VASCULOTROPIN A;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; TOOTH PULP; WESTERN BLOTTING;

BLOTTING, WESTERN; CATECHIN; CELLS, CULTURED; CYCLOOXYGENASE 2 INHIBITORS; DENTAL PULP; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84923093323     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/iej.12312     Document Type: Article

References (27)

1. Adachi T, Nakanishi T, Yumoto H et al. (2007) Caries-related bacteria and cytokines induce CXCL10 in dental pulp. Journal of Dental Research 86, 1217-22.
2. Artese L, Rubini C, Ferrero G et al. (2002) Vascular endothelial growth factor (VEGF) expression in healthy and inflamed human dental pulps. Journal of Endodontics 28, 20-3.
3. Chu SC, Tsai CH, Yang SF et al. (2004) Induction of vascular endothelial growth factor gene expression by proinflammatory cytokines in human pulp and gingival fibroblasts. Journal of Endodontics 30, 704-7.
4. Cohen JS, Reader A, Fertel R, Beck M, Meyers WJ (1985) A radioimmunoassay determination of the concentrations of prostaglandins E2 and F2 alpha in painful and asymptomatic human dental pulps. Journal of Endodontics 11, 330-5.
5. Güven G, Altun C, Gunhan O et al. (2007) Co-expression of cyclooxygenase-2 and vascular endothelial growth factor in inflamed human pulp: an immunohistochemical study. Journal of Endodontics 33, 18-20.
6. Hirao K, Yumoto H, Takahashi K et al. (2009) Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. Journal of Dental Research 88, 762-7.
7. Hirao K, Yumoto H, Nakanishi T et al. (2010) Tea catechins reduce inflammatory reactions via mitogen-activated protein kinase pathways in toll-like receptor 2 ligand-stimulated dental pulp cells. Life Sciences 86, 654-60.
8. Jung YD, Kim MS, Shin BA et al. (2001) EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. British Journal of Cancer 84, 844-50.
9. Kim SJ, Jeong HJ, Lee KM et al. (2007) Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. The Journal of Nutritional Biochemistry 18, 587-96.
10. Lin YL, Lin JK (1997) (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Molecular Pharmacology 52, 465-72.
11. Lin SK, Shun CT, Kok SH et al. (2008) Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis. Archives of Otolaryngology-Head & Neck Surgery 134, 522-7.
12. Matsushita K, Motani R, Sakuta T et al. (1999) Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture. Infection and Immunity 67, 1633-9.
13. Miyauchi M, Takata T, Ito H et al. (1996) Immunohistochemical demonstration of prostaglandins E2, F2 alpha, and 6-keto-prostaglandin F1 alpha in rat dental pulp with experimentally induced inflammation. Journal of Endodontics 22, 600-2.
14. Nakanishi T, Matsuo T, Ebisu S (1995) Quantitative analysis of immunoglobulins and inflammatory factors in human pulpal blood from exposed pulps. Journal of Endodontics 21, 131-6.
15. Nakanishi T, Shimizu H, Hosokawa Y, Matsuo T (2001) An immunohistological study on cyclooxygenase-2 in human dental pulp. Journal of Endodontics 27, 385-8.
16. Nakanishi T, Mukai K, Yumoto H et al. (2010) Anti-inflammatory effect of catechin on cultured human dental pulp cells affected by bacteria-derived factors. European Journal of Oral Sciences 118, 145-50.
17. Nie D, Honn KV (2002) Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cellular and Molecular Life Sciences: CMLS 59, 799-807.
18. Ohnishi T, Suwa M, Oyama T et al. (2000) Prostaglandin E2 predominantly induces production of hepatocyte growth factor/scatter factor in human dental pulp in acute inflammation. Journal of Dental Research 79, 748-55.
19. Smith WL, Dewitt DL (1996) Prostaglandin endoperoxide H synthases-1 and -2. Advances in Immunology 62, 167-215.
20. Staquet MJ, Durand SH, Colomb E et al. (2008) Different roles of odontoblasts and fibroblasts in immunity. Journal of Dental Research 87, 256-61.
21. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. International Immunology 17, 1-14.
22. Tani-Ishii N, Wang CY, Stashenko P (1995) Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. Oral Microbiology and Immunology 10, 213-9.
23. Tokuda H, Takai S, Matsushima-Nishiwaki R et al. (2007) (-)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts. Journal of Cellular Biochemistry 100, 1146-53.
24. Tran-Hung L, Mathieu S, About I (2006) Role of human pulp fibroblasts in angiogenesis. Journal of Dental Research 85, 819-23.
25. Tsujii M, Kawano S, DuBois RN (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proceedings of the National Academy of Sciences of the United States of America 94, 3336-40.
26. Yang F, Oz HS, Barve S et al. (2001) The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Molecular Pharmacology 60, 528-33.
27. Zhang Q, Tang X, Lu Q et al. (2006) Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Molecular Cancer Therapeutics 5, 1227-38.